Talabostat Recruiting Phase 2 Trials for Recurrent Malignant Solid Neoplasm / Advanced Malignant Solid Neoplasm Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04171219Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers